Biotechnology: The Patenting of DNA | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotechnology: The Patenting of DNA

An SI Board Since April 1999

Posts	SubjectMarks	Bans
37	12	0

Emcee: Mike McFarland	Type: Unmoderated

Introduction Compact

I borrowed this title from an article written
by John J. Doll, director Biotechnology Examination,
U.S. Patent and Trademark Office

Here is the url to the article in Science Magazine.
sciencemag.org

I started this thread so that we would have a
repository for relevant web links and a folder
into which I could place summaries of posts from
other threads--and links back to to them.

Any and all discussion of the genomics oriented stocks
is encouraged, with an emphasis on the sequencing
and bioinformatics companies.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
37	New York Times article on biotech patents: Message 12119496	RCMac	-	11/26/1999
36	Good summary of the main risk to genomic companies in HGSI's 8/16/99 S-3 fi	Steven Rachbach	-	8/22/1999
35	news and views article in august nature biotech by judah folkman on an interest	John Starks	-	8/4/1999
34	<i> What does a SNP tell you? "Somewhere in the DNA, there is a sequ	Mike McFarland	-	7/15/1999
33	Mike, <i>In fact, if I was born with a few genetic flaws that make me p	Biomaven	-	7/15/1999
32	<NBIX, you own that one?> Yes. DAK	LLCF	-	7/15/1999
31	I follow AFFX to the extent that a few of the companies in Mike's Microcap	Mike McFarland	-	7/15/1999
30	Mike, I know from the "Gorilla" thread that you also follow AFFX... I	LLCF	-	7/15/1999
29	And the classic example of a single amino acid change leading to a real differe	Pseudo Biologist	-	7/15/1999
28	Incyte has LifeProt, Celera--GeneTag, and Gene Logic is rolling out their Flow-	Mike McFarland	-	7/15/1999
27	<please help!> I'm not really the one to be chipping in here, as tec	LLCF	-	7/15/1999
26	Thread: A few more questions from the noisy bionewbie, please help! The estab	Mike McFarland	-	7/15/1999
25	< I know of a small biotech who, when looking for partnerships had a margin	LLCF	-	6/29/1999
24	There are also minimum royalties to consider (annual) and the upfront license f	Webhead	-	6/29/1999
23	RCM, thanks for reminding me of the article; very relevant to the discussion.	Pseudo Biologist	-	6/29/1999
22	< at some point the tool user may determine that is not worth pursuing a ris	LLCF	-	6/29/1999
21	PB, >>imagine that the drug developer used several "tools" (a g	RCMac	-	6/28/1999
20	>> For example, note how Immunex proceeded with development of Enbrel wit	scaram(o)uche	-	6/28/1999
19	Yes, but (again, I do not know the specifics for SIBI-PFE, so the stuff below s	Pseudo Biologist	-	6/28/1999
18	Of course, but surely you agree the terms before using the tool - if not, it&#	nigel bates	-	6/28/1999
17	I guess so, but, and this is not specific to SIBI but to any "tool",	Pseudo Biologist	-	6/28/1999
16	Surely it is up to SIBI what is "reasonable" for the use of their to	nigel bates	-	6/28/1999
15	One inflammatory paragraph from the Pfizer release <<"The patenting	Pseudo Biologist	-	6/27/1999
14	The post below (originally made to the SIBI board) triggered and interesting di	Pseudo Biologist	-	6/26/1999
13	Chuckle. Thanks, Mike, I had completely missed that. Audacity indeed!(eom)	scaram(o)uche	-	5/15/1999

Go to reply# or date (mm/dd/yy):